Zobrazeno 1 - 10
of 2 109
pro vyhledávání: '"S. Alva"'
Autor:
Nuria Tubau-Juni, Josep Bassaganya-Riera, Andrew J. Leber, Sameeksha S. Alva, Ryan Baker, Raquel Hontecillas
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Clostridioides difficile infection (CDI) is the leading cause of antibiotic-associated diarrhea, and its clinical symptoms can span from asymptomatic colonization to pseudomembranous colitis and even death. The current standard of care for C
Externí odkaz:
https://doaj.org/article/c6144bacee3149aaa47fc7de462e72ae
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Ocular immune-related adverse events are a relatively rare complication of immune checkpoint inhibitors. Common ocular toxicities range from dry eyes to inflammatory uveitis and ocular myasthenia gravis. Here, we present the case of a 55-year-old wom
Externí odkaz:
https://doaj.org/article/f5e9c2351f8d4e66b8403d6f5064d5e7
Autor:
G. M. S. ALVA, G. A. MONTANDON
Publikováno v:
Revista IBRACON de Estruturas e Materiais, Vol 12, Iss 5, Pp 1058-1085 (2019)
Abstract The behavior of single-storey, single-bay reinforced concrete infilled frame with masonry panel subjected to static horizontal load was studied using two structural models: i) equivalent strut model (ESM) and ii) model with two-dimensional f
Externí odkaz:
https://doaj.org/article/3f059038a80349b3917597e5e9ae516f
Autor:
Charles B. Nguyen, Ajjai S. Alva
Publikováno v:
Advances in Oncology. 3:129-136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c66eabed8bc8024dfd009788e761d0c3
https://doi.org/10.1016/j.yao.2023.01.009
https://doi.org/10.1016/j.yao.2023.01.009
Autor:
Vincent T. Ma, Charles S. Katzman, Phillip L. Palmbos, Rajiv M. Patel, Johann E. Gudjonsson, Ajjai S. Alva
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 1, Iss , Pp 100004- (2020)
Immune-mediated cutaneous reactions are a frequent occurrence in cancer patients treated with immune checkpoint inhibitors. A small subset of these adverse events are psoriasiform reactions. To date, there is no high-level evidence supporting the mos
Externí odkaz:
https://doaj.org/article/b542242dacf0436baa4cc6c44c36c7f7
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100251- (2020)
Introduction: Immune checkpoint inhibitors (CPIs) were recently approved in advanced clear cell renal cell carcinoma (RCC) and could be a promising option for metastatic RCC with sarcomatoid differentiation (sRCC) which otherwise carry a poor prognos
Externí odkaz:
https://doaj.org/article/9762f402e20a46e09a12e8c70dd1c421
Publikováno v:
Revista IBRACON de Estruturas e Materiais, Vol 11, Iss 4, Pp 834-855 (2018)
Abstract Conventional structural analysis of buildings in reinforced concrete is performed considering beam-column connections as rigid. However, experimental results prove the existence of relative rotations in beam-column connections of reinforced
Externí odkaz:
https://doaj.org/article/9e5b0d878f484758a6d065d1a0782475
Autor:
Robert S. Brzozowski, Mirella Huber, A. Maxwell Burroughs, Gianni Graham, Merryck Walker, Sameeksha S. Alva, L. Aravind, Prahathees J. Eswara
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Bacteria adapt to different environments by regulating cell division and several conditions that modulate cell division have been documented. Understanding how bacteria transduce environmental signals to control cell division is critical in understan
Externí odkaz:
https://doaj.org/article/2314ed69e60e4426801e98349f571187
Autor:
Arul M. Chinnaiyan, A. Robert MacLeod, Youngsoo Kim, Ajjai S. Alva, Xuhong Cao, Alice Xu, Kristin M. Juckette, Andrew Delekta, Esther Luo, Xiaojun Jing, Fengyun Su, Heng Zheng, Xiaoju Wang, Sudhanshu Shukla, Yuanyuan Qiao, Lisha Wang, Yajia Zhang, Abhijit Parolia, Mengyao Tan, Josh Vo, Jean C. Tien, Lanbo Xiao
Supplementary Table 1: List of the compounds in the epigenetic inhibitor library.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0056b26f4599a31c81525a93542a9cb
https://doi.org/10.1158/0008-5472.22419987.v1
https://doi.org/10.1158/0008-5472.22419987.v1
Autor:
Arul M. Chinnaiyan, A. Robert MacLeod, Youngsoo Kim, Ajjai S. Alva, Xuhong Cao, Alice Xu, Kristin M. Juckette, Andrew Delekta, Esther Luo, Xiaojun Jing, Fengyun Su, Heng Zheng, Xiaoju Wang, Sudhanshu Shukla, Yuanyuan Qiao, Lisha Wang, Yajia Zhang, Abhijit Parolia, Mengyao Tan, Josh Vo, Jean C. Tien, Lanbo Xiao
This file includes Supplementary Figures S1-S8. Figure S1: Inhibition of EPZ6438 and ASO-EZH2 sensitizes enzalutamide-resistant LNCaP cells to enzalutamide or ASO-AR. Figure S2: Design and validation of sgRNA targeting EZH2. Figure S3: Growth inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b74e293913dbca7b62487c878666eba
https://doi.org/10.1158/0008-5472.22419990.v1
https://doi.org/10.1158/0008-5472.22419990.v1